ACLS
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


This Article
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Sunderman FW,
Right arrow Articles by Wacinski, E.
Right arrow Search for Related Content
PubMed
Right arrow Articles by Sunderman FW, , Jr
Right arrow Articles by Wacinski, E.
Annals of Clinical and Laboratory Science, Vol 4, Issue 4, 299-305
Copyright © 1974 by Association of Clinical Scientists


Articles

Use of teflon digestion bombs for tissue analysis: measurements of the effect of estradiol-17 beta upon hepatic copper in rats

Sunderman FW Jr and ET Wacinski

Teflon digestion bombs have been used for pressure decomposition of rat liver samples preliminary to copper analyses by atomic absorption spectrometry. The analytical procedure is convenient and is consistently free from copper contamination. The recovery of copper added to liver samples (three mug Cu added per g wet wt) averaged 102 (S.D. plus or minus 3) percent. The accuracy of the copper analyses was verified by use of National Bureau of Standards reference bovine liver. The mean concentration of copper in perfused livers of 16 untreated male rats averaged 16.1 (S.D. plus or minus 2.3) mug per g dry wt. The mean concentration of copper in perfused livers of 8 male rats which received estradiol-17 beta in dosage of 50 mug per day, s.c., for 21 consecutive days was 21.7 (S.D. plus or minus 4.7) mug per g dry wt (p vs controls equals greater than 0.01). This study demonstrates that estrogen administration can cause a significant increase in the concentration of hepatic copper.





HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Copyright © 1974 by the Association of Clinical Scientists.